STOCK TITAN

[Form 4] Marpai, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Marpai, Inc. (MRAI) reported an insider equity transaction. A director acquired 50,000 shares of Class A common stock on 10/20/2025 at a reported price of $0.00, reflecting settlement of RSUs that were deemed fully vested on the issuance date.

Following the transaction, the reporting person beneficially owns 175,000 shares, held directly. The filing was made on Form 4 and indicates the transaction type as an acquisition.

Marpai, Inc. (MRAI) ha comunicato una operazione di equity insider. Un direttore ha acquisito 50.000 azioni ordinarie di Classe A il 20/10/2025 a un prezzo riportato di $0.00, riflettendo la liquidazione di RSU che sono state considerate completamente maturate al momento dell'emissione.

A seguito dell'operazione, la persona che presenta la dichiarazione detiene beneficiariamente 175.000 azioni, detenute direttamente. La dichiarazione è stata presentata tramite Form 4 e indica il tipo di operazione come acquisto.

Marpai, Inc. (MRAI) informó una transacción de insider de capital. Un director adquirió 50,000 acciones ordinarias de Clase A el 20/10/2025 a un precio reportado de $0.00, reflejando la liquidación de RSU que se consideraron plenamente adquiridas en la fecha de emisión.

Después de la transacción, la persona que presenta el informe posee de forma beneficiosa 175,000 acciones, mantenidas directamente. La presentación se realizó en Form 4 y indica el tipo de operación como una adquisición.

Marpai, Inc. (MRAI)가 내부자 주식 거래를 보고했습니다. 이사는 Classe A 보통주 50,000주2025-10-20에 매수했으며 보고된 가격은 $0.00로, 발행일에 완전히 취득한 것으로 간주되던 RSU의 정산을 반영합니다.

거래 후 보고자는 직접 보유한 175,000주를 이익상으로 보유합니다. 신고서는 Form 4로 제출되었고 거래 유형을 취득으로 표시합니다.

Marpai, Inc. (MRAI) a annoncé une opération d'initié sur actions. Un administrateur a acquis 50 000 actions ordinaires de Classe A le 20/10/2025 à un prix déclaré de $0.00, reflétant le règlement des RSU qui étaient considérées pleinement acquises à la date d'émission.

À la suite de la transaction, la personne qui déclare détient bénéficiairement 175 000 actions, détenues directement. Le dépôt a été effectué sur le formulaire 4 et indique le type de transaction comme acquisition.

Marpai, Inc. (MRAI) berichtete über eine Insider-Eigenkapitaltransaktion. Ein Direktor erwarb am 20.10.2025 50.000 Class-A-Stammaktien zu einem gemeldeten Preis von $0.00, was der Abrechnung von RSUs entspricht, die zum Ausgabedatum als vollständig erworben galten.

Nach der Transaktion besitzt die meldende Person beneficial 175.000 Aktien, direkt gehalten. Die Meldung wurde im Formular 4 eingereicht und gibt die Transaktion als Erwerb an.

ماربي، إنك (MRAI) أبلغت عن صفقة أسهم داخلية. قام مدير بشراء 50,000 سهماً من الأسهم العادية من الفئة A في 20/10/2025 بسعر مُعلَن قدره $0.00، وهذا يعكس تسوية RSU التي اعتُبرت كاملة الاستحقاق عند تاريخ الإصدار.

بعد الصفقة، يمتلك الشخص المُبلغ عنه بشكل مَنفَع 175,000 سهم بشكل مباشر. تم تقديم الإبلاغ باستخدام النموذج 4 وتُشير الصفقة إلى أنها من نوع استحواذ.

Marpai, Inc.(MRAI) 报告了一笔内部人股权交易。 一名董事在 2025/10/20 以披露价 $0.00 购买了 50,000 股 A 类普通股,反映了在发行日被视为已完全归属的 RSU 的结算。

交易完成后,报告人受益拥有直接持有的 175,000 股。 该申报以 Form 4 提交,交易类型显示为 取得

Positive
  • None.
Negative
  • None.

Marpai, Inc. (MRAI) ha comunicato una operazione di equity insider. Un direttore ha acquisito 50.000 azioni ordinarie di Classe A il 20/10/2025 a un prezzo riportato di $0.00, riflettendo la liquidazione di RSU che sono state considerate completamente maturate al momento dell'emissione.

A seguito dell'operazione, la persona che presenta la dichiarazione detiene beneficiariamente 175.000 azioni, detenute direttamente. La dichiarazione è stata presentata tramite Form 4 e indica il tipo di operazione come acquisto.

Marpai, Inc. (MRAI) informó una transacción de insider de capital. Un director adquirió 50,000 acciones ordinarias de Clase A el 20/10/2025 a un precio reportado de $0.00, reflejando la liquidación de RSU que se consideraron plenamente adquiridas en la fecha de emisión.

Después de la transacción, la persona que presenta el informe posee de forma beneficiosa 175,000 acciones, mantenidas directamente. La presentación se realizó en Form 4 y indica el tipo de operación como una adquisición.

Marpai, Inc. (MRAI)가 내부자 주식 거래를 보고했습니다. 이사는 Classe A 보통주 50,000주2025-10-20에 매수했으며 보고된 가격은 $0.00로, 발행일에 완전히 취득한 것으로 간주되던 RSU의 정산을 반영합니다.

거래 후 보고자는 직접 보유한 175,000주를 이익상으로 보유합니다. 신고서는 Form 4로 제출되었고 거래 유형을 취득으로 표시합니다.

Marpai, Inc. (MRAI) a annoncé une opération d'initié sur actions. Un administrateur a acquis 50 000 actions ordinaires de Classe A le 20/10/2025 à un prix déclaré de $0.00, reflétant le règlement des RSU qui étaient considérées pleinement acquises à la date d'émission.

À la suite de la transaction, la personne qui déclare détient bénéficiairement 175 000 actions, détenues directement. Le dépôt a été effectué sur le formulaire 4 et indique le type de transaction comme acquisition.

Marpai, Inc. (MRAI) berichtete über eine Insider-Eigenkapitaltransaktion. Ein Direktor erwarb am 20.10.2025 50.000 Class-A-Stammaktien zu einem gemeldeten Preis von $0.00, was der Abrechnung von RSUs entspricht, die zum Ausgabedatum als vollständig erworben galten.

Nach der Transaktion besitzt die meldende Person beneficial 175.000 Aktien, direkt gehalten. Die Meldung wurde im Formular 4 eingereicht und gibt die Transaktion als Erwerb an.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Calabrese Jennifer Rosario

(Last) (First) (Middle)
C/O MARPAI, INC.
615 CHANNELSIDE DRIVE, SUITE 207

(Street)
TAMPA FL 33602

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Marpai, Inc. [ MRAI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/20/2025 A 50,000(1) A $0.00 175,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The RSUs are deemed fully vested on the issuance date,
/s/ Jennifer Calabrese 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Marpai (MRAI) disclose?

A director acquired 50,000 shares of Class A common stock on 10/20/2025.

What was the reported transaction price for the MRAI shares?

The reported price was $0.00, consistent with settlement of RSUs.

How many Marpai (MRAI) shares does the insider own after the transaction?

The reporting person beneficially owns 175,000 shares after the transaction.

What was the nature of the equity award involved?

The filing notes the RSUs are deemed fully vested on the issuance date.

What is the insider’s relationship to Marpai (MRAI)?

The reporting person is a Director of Marpai, Inc.

Was ownership reported as direct or indirect?

Ownership was reported as Direct (D).
Marpai Inc

OTC:MRAI

MRAI Rankings

MRAI Latest News

MRAI Latest SEC Filings

MRAI Stock Data

6.70M
4.05M
49.81%
10.8%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
TAMPA